• No results found

TOWARDS THERAPIES FOR

N/A
N/A
Protected

Academic year: 2021

Share "TOWARDS THERAPIES FOR "

Copied!
2
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

Cover Page

The handle http://hdl.handle.net/1887/62785 holds various files of this Leiden University dissertation

Author: Pasteuning-Vuhman, Svitlana

Title: Towards therapies for muscular dystrophies : targeting TGF-beta and myostatin signalling to improve muscle quality and development of reliable outcome measures for preclinical mouse models

Date: 2018-06-07

(2)

Svitlana Pasteuning-Vuhman

Targeting TGF-beta and Myostatin signalling to improve muscle quality and development of reliable outcome

measures for preclinical mouse models

TOWARDS THERAPIES FOR MUSCULAR DYSTROPHIESSvitlana Pasteuning-Vuhman

TOWARDS THERAPIES FOR

MUSCULAR DYSTROPHIES

Referenties

GERELATEERDE DOCUMENTEN

In Chapter 2, we investigated three microRNAs: miR-371a-3p, miR-373-3p and miR-367-3p as putative tumor biomarkers during and after treatment with cisplatin combination

Daarnaast hebben we onderzocht hoe humane testiskanker cellijnen en op humane testiskanker-gebaseerde diermodellen gevoelig kunnen worden gemaakt voor cisplatine.. Het doel van

Novel preclinical models, therapies and biomarkers for testicular cancer Rosas Plaza,

Novel preclinical models, therapies and biomarkers for testicular cancer Rosas Plaza,

Novel preclinical models, therapies and biomarkers for testicular cancer Rosas Plaza,

Title: Towards therapies for muscular dystrophies : targeting TGF-beta and myostatin signalling to improve muscle quality and development of reliable outcome measures for

Title: Towards therapies for muscular dystrophies : targeting TGF-beta and myostatin signalling to improve muscle quality and development of reliable outcome measures for

Title: Towards therapies for muscular dystrophies : targeting TGF-beta and myostatin signalling to improve muscle quality and development of reliable outcome measures for